Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT
· Real-Time Price · USD
26.67
0.22 (0.83%)
At close: Aug 15, 2025, 3:59 PM
26.50
-0.64%
After-hours: Aug 15, 2025, 07:37 PM EDT
Summit Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 297.87M | 211.53M | 104.86M | 93.78M | 28.75M | 61.29M | 71.42M | 23.79M | 42.12M | 70.97M | 348.61M | 121.97M | 57.34M | 77.45M | 71.79M | 80.25M | 103.39M | 102.19M |
Short-Term Investments | n/a | 149.79M | 307.49M | 393.12M | 297.04M | 95.39M | 114.82M | 175.15M | 172.9M | 170.96M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 42.12M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 6.52M | 4.14M | 2.55M | 2.33M | 2.24M | 2.09M | 5.28M | 5.08M | 254K | 691K | 577K | 3.44M | 2.5M | 1.82M | 170K | 11.31M | 7.85M | n/a |
Receivables | n/a | n/a | 557K | 660K | n/a | 945K | 848K | 812K | 4.61M | 5.69M | 349K | 140K | 1.11M | 1.08M | 1.46M | 12.36M | 11.41M | 14.04M |
Inventory | n/a | n/a | n/a | n/a | n/a | 317K | 2.44M | 5.07M | 6.09M | n/a | 301.5M | 1.62M | n/a | 4.35M | 7.16M | 8.41M | 5.73M | 8M |
Other Current Assets | 11.37M | 9.44M | 10.84M | 1.99M | 3.33M | 5.32M | 181K | 120K | 1.79M | 409K | 300.49M | 428K | 12.59M | 1.48M | 1.2M | 1.19M | 963K | 985K |
Total Current Assets | 309.24M | 370.75M | 423.75M | 490.29M | 328.79M | 163.26M | 189.71M | 204.95M | 227.5M | 248.03M | 656.71M | 137.12M | 79.4M | 99.44M | 97.31M | 102.21M | 121.48M | 125.22M |
Property-Plant & Equipment | 6.24M | 7M | 7.4M | 8.24M | 8.94M | 9.55M | 6.06M | 6.63M | 7.22M | 4.34M | 5.08M | 5.16M | 3.11M | 3.4M | 3.48M | 2.54M | 2.97M | 2.17M |
Goodwill & Intangibles | 2.04M | 1.92M | 1.86M | 1.99M | 1.88M | 1.88M | 1.89M | 1.81M | 1.88M | 1.84M | 1.8M | 9.61M | 10.71M | 11.82M | 12.41M | 12.61M | 13.22M | 13.41M |
Total Long-Term Assets | 14.8M | 13.07M | 11.81M | 12.56M | 13.06M | 13.52M | 13.24M | 13.53M | 9.87M | 6.87M | 7.46M | 18.21M | 16.32M | 17.04M | 16.06M | 26.46M | 24.04M | 15.58M |
Total Assets | 324.04M | 383.82M | 435.56M | 502.85M | 341.86M | 176.78M | 202.95M | 218.48M | 237.37M | 254.9M | 664.17M | 155.33M | 95.72M | 116.47M | 113.37M | 128.67M | 145.52M | 140.79M |
Account Payables | 22.98M | 4.99M | 4.64M | 3.25M | 3.34M | 6.37M | 2.67M | 3.31M | 987K | 710K | 355K | 1.43M | 3.57M | 6.96M | 4.37M | 5.88M | 6.95M | 4.11M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | 12.58M | 14.21M | 7.16M | 7.4M | n/a | n/a | n/a | 3.23M | 5.1M | 7.94M | 7.51M | 7.14M | 7.42M |
Short-Term Debt | 3.12M | 3.54M | n/a | 24.5M | 100M | n/a | n/a | 100M | n/a | n/a | 19.77M | n/a | n/a | n/a | 284.24K | n/a | n/a | 54.96M |
Other Current Liabilities | 57.21M | 26.34M | 13.77M | 19.5M | 5.68M | 6.82M | 6.15M | 3.99M | 4.15M | 2.74M | 6.3M | 2.72M | 2.17M | 2.19M | 5.31M | 1.03M | 661K | 581K |
Total Current Liabilities | 60.33M | 34.88M | 41.73M | 59.01M | 140.17M | 23.44M | 20.41M | 113.74M | 11.93M | 17.44M | 38.78M | 16.68M | 15.17M | 22.72M | 25.62M | 22.79M | 21.89M | 73.05M |
Long-Term Debt | 2.44M | n/a | n/a | n/a | n/a | 100M | 100M | n/a | 100M | 100M | 494.54M | n/a | 25.31M | 25.05M | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 1.84M | 1.71M | 1.63M | 1.72M | 1.6M | 3.31M | 1.56M | 1.48M | 1.51M | 1.48M | 1.43M | 2.42M | 2.59M | 2.75M | 3.22M | 2.69M | 2.69M | 2.6M |
Total Long-Term Liabilities | 4.27M | 4.62M | 5.08M | 5.92M | 6.61M | 109.13M | 104.85M | 5.36M | 105.84M | 103.97M | 498.73M | 5.4M | 29.23M | 29.34M | 4.47M | 3.59M | 4.2M | 3.34M |
Total Liabilities | 64.6M | 39.49M | 46.81M | 64.93M | 146.78M | 132.57M | 125.26M | 119.1M | 117.77M | 121.42M | 537.51M | 22.08M | 44.4M | 52.06M | 30.09M | 26.38M | 26.09M | 76.39M |
Total Debt | 5.55M | 6.45M | 7.22M | 32.5M | 108.7M | 109.52M | 106.1M | 106.66M | 107.26M | 104.18M | 518.76M | 4.37M | 27.32M | 27.5M | 2.78M | 1.84M | 2.15M | 56.37M |
Common Stock | 7.43M | 7.42M | 7.38M | 7.37M | 7.24M | 7.02M | 7.02M | 6.98M | 6.98M | 6.98M | 2.11M | 2.01M | 981K | 981K | 980K | 976K | 974K | 829K |
Retained Earnings | -1.84B | -1.28B | -1.21B | -1.15B | -1.1B | -1.04B | -993.26M | -956.69M | -935.42M | -920.71M | -378.33M | -359.1M | -337.72M | -320.94M | -299.55M | -272.45M | -255.43M | -231.55M |
Comprehensive Income | -2.75M | -2.56M | -2.29M | -2.31M | -2.5M | -2.45M | -2.45M | -2.32M | -2.44M | -1.4M | -1.89M | -3.22M | -3.17M | -3.96M | -2.2M | -3.44M | -2.58M | -3.12M |
Shareholders Equity | 259.44M | 344.33M | 388.75M | 437.92M | 195.07M | 44.21M | 77.69M | 99.38M | 119.6M | 133.48M | 126.65M | 133.25M | 51.32M | 64.41M | 83.28M | 102.3M | 119.43M | 64.41M |
Total Investments | n/a | 149.79M | 307.49M | 393.12M | 297.04M | 95.39M | 114.82M | 175.15M | 215.01M | 170.96M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |